Fig. 1: Overview of time since menopause (TSM), metabolomic signature and cardiovascular diseases (CVD) prediction in women.

MI myocardial infarction, IHD chronic ischemic heart disease, HF heart failure, AF atrial fibrillation, MHT menopausal hormone therapy, AUC area under the curve, NRI net reclassification improvement.